TG Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:NKB2 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Nov 24	Sell€708,752	Laurence Charney	Individual	25,000	€28.35
11 Nov 24	Sell€142,901	Sagar Lonial	Individual	5,000	€28.58
05 Nov 24	Sell€448,425	Yann Echelard	Individual	20,000	€22.42
20 Jun 24	Sell€403,972	Sagar Lonial	Individual	25,933	€15.74
13 Mar 24	Sell€72,799	Sagar Lonial	Individual	5,000	€14.56
12 Mar 24	Sell€321,792	Laurence Charney	Individual	22,000	€14.63
05 Jan 24	Sell€303,685	Laurence Charney	Individual	17,500	€17.35

Insider Trading Volume

Insider Buying: NKB2 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of NKB2?
Owner Type	Number of Shares	Ownership Percentage
State or Government	46,655	0.0325%
Individual Insiders	9,920,084	6.91%
General Public	26,192,970	18.3%
Institutions	107,359,627	74.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.3%	BlackRock, Inc.	21,956,197	€644.0m	92.8%	0.01%
10.7%	The Vanguard Group, Inc.	15,387,290	€451.3m	12.4%	0.01%
6.34%	State Street Global Advisors, Inc.	9,094,158	€266.7m	35.8%	0.01%
5.71%	Michael Weiss	8,200,919	€240.5m	0%	no data
3.4%	Opus Point Partners	4,874,010	€143.0m	0%	100.0%
2.5%	Pictet Asset Management Limited	3,582,583	€105.1m	10.5%	0.1%
2.23%	Geode Capital Management, LLC	3,205,228	€94.0m	-0.04%	0.01%
1.79%	Woodline Partners LP	2,565,322	€75.2m	80.7%	0.71%
1.77%	Soleus Capital Management, L.P.	2,534,540	€74.3m	-30.5%	6.26%
1.59%	Opaleye Management Inc.	2,280,000	€66.9m	0%	12.5%
1.41%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	2,020,808	€59.3m	20.2%	0.02%
1.25%	Morgan Stanley, Investment Banking and Brokerage Investments	1,798,924	€52.8m	31.1%	0.01%
1.2%	Deep Track Capital, LP	1,725,000	€50.6m	-39.9%	1.73%
1.16%	Bank of America Corporation, Asset Management Arm	1,660,998	€48.7m	-19.6%	0.02%
1.14%	Hood River Capital Management LLC	1,630,349	€47.8m	3.65%	0.8%
0.98%	Northern Trust Global Investments	1,412,144	€41.4m	10.6%	0.01%
0.91%	Goldman Sachs Group, Investment Banking and Securities Investments	1,311,266	€38.5m	38.7%	0.02%
0.87%	Goldman Sachs Asset Management, L.P.	1,245,161	€36.5m	9.29%	0.01%
0.83%	Charles Schwab Investment Management, Inc.	1,184,609	€34.7m	0.67%	0.01%
0.82%	FMR LLC	1,183,885	€34.7m	-2.59%	no data
0.79%	683 Capital Management, LLC	1,135,000	€33.3m	-18.9%	3.74%
0.74%	Two Sigma Investments, LP	1,062,860	€31.2m	-21.9%	0.08%
0.67%	UBS Asset Management AG	959,882	€28.2m	14%	no data
0.58%	Susquehanna International Group, LLP, Asset Management Arm	830,692	€24.4m	-36.9%	0.04%
0.57%	BNY Asset Management	824,590	€24.2m	67.4%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 16:00
End of Day Share Price	2025/01/02 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TG Therapeutics, Inc. is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alec Stranahan	BofA Global Research
Jonathan Aschoff	Brean Capital
Mayank Mamtani	B. Riley Securities, Inc.